Dickkopf-3 attenuates pressure overload-induced cardiac remodelling

Cardiovascular Research

Volumn 102, Issue 1, 2014, Pages 35-45

  Zhang, Yan ^a,b   Liu, Yu ^a,b   Zhu, Xue Hai ^c   Zhang, Xiao Dong ^b   Jiang, Ding Sheng ^a,b   Bian, Zhou Yan ^a,b   Zhang, Xiao Fei ^b   Chen, Ke ^b   Wei, Xiang ^c   Gao, Lu ^c   Zhu, Li Hua ^a,b   Yang, Qinglin ^d   Fan, Guo Chang ^e   Lau, Wayne B ^f   Ma, Xinliang ^f   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

ASK1; Cardiac hypertrophy; DKK3; Fibrosis

Indexed keywords

ALPHA ACTININ; APOPTOSIS SIGNAL REGULATING KINASE 1; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; DICKKOPF 3 PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN HEAVY CHAIN BETA; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; DKK3 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME INACTIVATION; GAIN OF FUNCTION MUTATION; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; C57BL MOUSE; CARDIOMEGALY; DRUG EFFECTS; GENETICS; HEART MUSCLE; HEART VENTRICLE REMODELING; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CARDIOMEGALY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRESSURE; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84896989506     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu004     Document Type: Article

References (41)

1. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA 2011;306:1669-1678.
2. Drazner MH. The progression of hypertensive heart disease. Circulation 2011;123: 327-334.
3. Li H, Tang QZ, Liu C, Moon M, Chen M, Yan L et al. Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice. Hypertension 2010;56:1109-1117.
4. Kang YJ. Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death. Toxicol Pathol 2006;34:58-66.
5. Li H, He C, Feng J, Zhang Y, Tang Q, Bian Z et al. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci USA 2010;107:13818-13823.
6. Jiang DS, Bian ZY, Zhang Y, Zhang SM, Liu Y, Zhang R et al. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 2013;61: 1193-1202.
7. Jiang DS, Luo YX, Zhang R, Zhang XD, Chen HZ, Zhang Y et al. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension 2013;63:119-127.
8. Niehrs C. Function and biological rolesofthe Dickkopf family of Wnt modulators. Onco-gene 2006;25:7469-7481.
9. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L et al. Functional and structural diversity of the human Dickkopf gene family. Gene 1999;238:301-313.
10. Monaghan AP, Kioschis P, Wu W, Zuniga A, Bock D, Poustka A et al. Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev 1999;87:45-56.
11. Mallarino R, Campas O, Fritz JA, Burns KJ, Weeks OG, Brenner MP et al. Closely related bird species demonstrate flexibility between beak morphology and underlying developmental programs. Proc Natl Acad Sci USA 2012;109:16222-16227.
12. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S et al. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 2005;65: 9617-9622.
13. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM. Regulationofpros-tate cell growth and morphogenesis by Dickkopf-3. Oncogene 2006;25:6528-6537.
14. Papatriantafyllou M, Moldenhauer G, Ludwig J, Tafuri A, Garbi N, Hollmann G et al. Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance. Proc Natl Acad Sci USA 2012;109:1631-1636.
15. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J et al. Dkk3, downregulatedincervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 2009;124:287-297.
16. Mizobuchi Y, Matsuzaki K, Kuwayama K, Kitazato K, Mure H, Kageji T et al. REIC/Dkk-3 induces cell death in human malignant glioma. Neuro Oncol 2008;10:244-253.
17. Koppen A, Ait-Aissa R, Koster J, Ora I, Bras J, van Sluis PGet al. Dickkopf-3 expression isa marker for neuroblastic tumor maturation and is down-regulated by MYCN. Int J Cancer 2008;122:1455-1464.
18. Oceandy D, Pickard A, Prehar S, Zi M, Mohamed TM, Stanley PJ et al. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation 2009;120:607-616.
19. Huang H, Tang QZ, Wang AB, Chen M, Yan L, Liu C et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension 2010;56:232-239.
20. Jiang DS, Zhang XF, Gao L, Zong J, Zhou H, Liu Y et al. Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of Toll-like receptor 4 signaling. Hypertension 2013;63:96-104.
21. Lu J, Bian ZY, Zhang R, Zhang Y, Liu C, Yan L et al. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res Cardiol 2013;108:326.
22. Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH et al. Targeted cardiacoverexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 2007;115:1885-1894.
23. Yi W, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang Xet al. C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and car-dioprotective molecule in the ischemic mouse heart. Circulation 2012;125:3159-3169.
24. Jung H, Seong HA, Manoharan R, Ha H. Serine-threonine kinase receptor-associated protein inhibits apoptosis signal-regulating kinase 1 function through direct interaction. J Biol Chem 2010;285:54-70.
25. Park HS, Cho SG, Kim CK, Hwang HS, Noh KT, Kim MS et al. Heatshockprotein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol 2002;22: 7721-7730.
26. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7:589-600.
27. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275:90-94.
28. Xiao J, Moon M, Yan L, Nian M, Zhang Y, Liu C et al. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction. Basic Res Cardiol 2012; 107:239.
29. Takeda K, Matsuzawa A, Nishitoh H, Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 2003;28:23-29.
30. Zhang H, Tao L, Jiao X, Gao E, Lopez BL, Christopher TA et al. Nitrative thioredoxin in-activation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic Biol Med 2007;43:39-47.
31. Tao L, Jiao X, Gao E, Lau WB, Yuan Y, Lopez B et al. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 2006;114: 1395-1402.
32. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A et al. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res 2003;93:874-883.
33. Yamaguchi O, Higuchi Y, Hirotani S, Kashiwase K, Nakayama H, Hikoso S et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 2003;100:15883-15888.
34. Taniike M, Yamaguchi O, Tsujimoto I, Hikoso S, Takeda T, Nakai A et al. Apoptosis signal-regulating kinase 1/p38 signalingpathway negatively regulates physiological hypertrophy. Circulation 2008;117:545-552.
35. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in trans-genic mice. EMBO J 2000;19:6341-6350.
36. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010;90:1507-1546.
37. Hsieh SY, Hsieh PS, Chiu CT, Chen WY. Dickkopf-3/REIC functionsasasuppressor gene of tumor growth. Oncogene 2004;23:9183-9189.
38. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H et al. Overex-pression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 2009;284:14236-14244.
39. Ochiai K, Watanabe M, Ueki H, Huang P, Fujii Y, Nasu Y et al. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochem Biophys Res Commun 2011; 412:391-395.
40. Nakamura RE, Hackam AS. Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 2010;28:232-242.
41. Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P et al. Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol 2010;37:1495-1501.